Citation tools
"Abstract A003: Safety and preliminary efficacy of ACTR707, autologous T lymphocytes expressing an antibody-coupled T-cell receptor, in combination with rituximab in subjects with relapsed or refractory CD20-positive B-cell lymphoma." Cancer Immunology Research
7.2 Supplement
(2019):
A003.
Web. 26 Feb. 2021.